---
title: "Avalanche Treasury schedules conference call for Q2 2026 results"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295803065.md"
description: "Avalanche Treasury Co. has scheduled a conference call for August 26, 2026, at 4:00 p.m. ET to discuss its Q2 2026 financial results. The event will be webcast."
datetime: "2026-08-13T13:00:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295803065.md)
  - [en](https://longbridge.com/en/news/295803065.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295803065.md)
generator: "portal-rs"
---

# Avalanche Treasury schedules conference call for Q2 2026 results

-   Avalanche Treasury Co. will hold a conference call on Aug. 26, 2026 at 4:00 p.m. ET to discuss Q2 2026 results. \* Webcast access: here Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avalanche Treasury Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20260813623978) on August 13, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [AVAT.US](https://longbridge.com/en/quote/AVAT.US.md)

## Related News & Research

- [Avalanche Treasury Corp 2Q 2026: Revenue $1.55M, Net loss $(44.66M) — 10-Q Summary](https://longbridge.com/en/news/296403115.md)
- [Itera ASA to present preliminary Q2 2026 results via webcast](https://longbridge.com/en/news/296590225.md)
- [IRLAB Therapeutics to webcast interim report presentation](https://longbridge.com/en/news/296470410.md)
- [Eolus schedules webcast, teleconference to present Q2 interim report](https://longbridge.com/en/news/296458713.md)
- [Frontline schedules Q2 2026 results webcast and conference call](https://longbridge.com/en/news/296622834.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**